IFNG and acute myeloid leukemia: Furthermore, a report by Clemenceau and colleagues combined IFN-γ ELISpoT and flow cytometry for quantifying cellular immunity in AML and MDS patients receiving allogeneic stem cell therapy identifying spike-specific IFN-γ and TNF-α secreting cells within CD4+ and CD8+ T-cell populations.